about
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief ...
Read More
1.42
-0.02
(-1.39%)
112.1K
XNAS Volume
XNAS 12 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
PainReform Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..